Search
for
Sort by
Research 841–870 of 1000+
- The relevance of using 5α-reductase inhibitors in the conservative management of benign prostatic hyperplasia: A review
- Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.
- Pemphigus and associated comorbidities: a cross-sectional study
- Determination of Finasteride in Tablets by High Performance Liquid Chromatography
- PSS34 THE IMPACT OF POTENTIAL PILL SPLITTING ON GENERIC AND BRANDED FINASTERIDE UPTAKE
- Non-Steroidal Modulation of the 5-Alpha Reductase Axis: A Dual Therapeutic Strategy for Prostatic Chemoprevention and Androgenetic Alopecia
- 5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review
- Molecular Interactions of New Pregnenedione Derivatives
- Isolation and Structural Characterization of Finasteride Degradation Products by Preparative HPLC, HRMS, and NMR
- Simultaneous Quantification of Dutasteride and Silodosin Using a Stability-Indicating RP-HPLC Approach
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- Male Breast Cancer and 5α-Reductase Inhibitors Finasteride and Dutasteride
- Finasteride Use Is Associated with Higher Odds of Obstructive Sleep Apnea: Results from the US Food and Drug Administration Adverse Events Reporting System.
- Suspected adverse reactions to medications and food supplements containing <i>Serenoa repens</i>: A worldwide analysis of pharmacovigilance and phytovigilance spontaneous reports
- Serenoa repens (saw palmetto) for Lower Urinary Tract Symptoms (LUTS): The Evidence for Efficacy and Safety of Lipidosterolic Extracts. Part III
- Serenoa repens: A Phytochemical and Pharmacological Review
- Editorial Comment
- A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women.
- Finasteride as a Neo-Adjuvant Treatment for TURPLiterature Review
- Synthesis and Evaluation of 2‘-Substituted 4-(4‘-Carboxy- or 4‘-carboxymethylbenzylidene)-<i>N</i>-acylpiperidines: Highly Potent and in Vivo Active Steroid 5α-Reductase Type 2 Inhibitors
- <i>Serenoa repens</i> as an Endocrine Disruptor in a 10-Year-Old Young Girl: A New Case Report
- Acute urinary retention: risks and management.
- Anti-nociceptive and anti-inflammatory properties of 5alpha-reductase inhibitor finasteride in experimental animals
- MP85-05 SEXUAL DYSFUNCTION AFTER 5-ALPHA REDUCTASE INHIBITOR USE: INSIGHTS FROM THE REDUCE STUDY GROUP DATABASE
- Eficacia de la combinación de doxazosina y finasterida en la hipertrofia benigna de próstata
- Risk of Depression after 5 Alpha Reductase Inhibitor Medication: Meta-Analysis
- MP73-14 TRANSURETHRAL RESECTION URINARY RETENTION PREDICTOR (TURP) SCORE: A NOVEL PERIOPERATIVE PREDICTOR OF POST-OPERATIVE URINARY RETENTION
- How to Read a Research Paper
- Оптимизация подходов консервативной терапии доброкачественной гиперплазии предстательной железы ингибиторами 5-альфаредуктазы. Клинико-морфологическое исследование
- T07-O-05 Finasteride 5 mg and sexual side effects. How many of these are related to a nocebo phenomenon?